Research Report on Assisted Reproductive Technology (ART) Market Revenue, Industry Growth and Demand Analysis to 2028

Emerging research logo

Market Trends – Technological Advancements

VANCOUVER, BC, USA, April 18, 2022 / — Global assisted reproductive technology market size expected to reach USD 54.75 billion with a stable revenue CAGR of 9.7% in 2028, according to the latest analysis from Emergen Research. Revenue growth of the Assisted Reproductive Technology (ART) market is driven by the growing popularity of in vitro fertilization (IVF) (with or without intracytoplasmic sperm injection (ICSI)) and artificial insemination, among other technologies .
Infertility is a multi-faceted problem involving social, cultural and economic implications, which can reach threatening proportions in countries with lower fertility rates. According to statistics published by the WHO, approximately 48 million couples and 186 million people live with infertility worldwide. The increasing incidence of ovulation problems with irregular or no periods is a common cause of infertility in women. Increased awareness of various fertility treatments among the younger generation and more women opting for such fertility treatments are driving the growth of the market.
Get Sample Report @
The study offers comprehensive coverage of the qualitative and quantitative analysis of the Assisted Reproductive Technology (ART) market along with crucial statistical data of the Assisted Reproductive Technology (ART) market. The research study provides historical data and offers an accurate estimation of the forecast till 2028. The report also introduces the established and emerging players of the market, covering business overview, product portfolio, strategic alliances and business expansion strategies.
Some of the key players in the market report include Origio, Cryolab Ltd., Bloom IVF Center, Ferring Pharmaceuticals, Cosmos Biomedical, Irvine Scientific, European Sperm Bank, Ovascience, Parallabs, and Microm UK Ltd.
Report Highlights
In June 2020, Ferring Pharmaceuticals announced a two-year collaboration with Igenomix for innovative disease mechanism research and target discovery in conditions associated with infertility and pregnancy, such as preeclampsia, to develop approaches breakthrough diagnostics and therapeutics to meet strong unmet demand. A new center in Boston has been created which will bring together experts from both companies and the objective is to study molecular structures, develop functional genomic systems and create tools to study embryo implantation, among others.
The revenue from the frozen non-donor segment is expected to register a significantly rapid growth rate over the forecast period owing to its established reliability and higher pregnancy success rate. The cost of the procedure is lower than cycles using fresh embryos and eggs. A frozen transfer is much simpler for the reproductive endocrinologist and the patient. This procedure is also less mentally and physically stressful on a woman’s body.
Request Report Discount @
The report is an investigative study of technological developments and product advancements, along with regional analysis for each product and application offered in the market. The basic objective of the report is to provide an insight into how the Assisted Reproductive Technology (ART) industry works. It provides an accurate and strategic view of the market with an in-depth assessment of market segments and sub-segments. It offers a panoramic view of the industry to provide a deeper understanding of the global industry.
Emergen Research has segmented the global assisted reproductive technology market based on procedure, technology, end-use, and region:
Procedural Outlook (Revenue, USD Billion; 2018-2028)
fresh donor
Fresh non-donor
Donor Frozen
Non-donor frozen
Egg/embryo bank
Technology Outlook (Revenue, USD Billion; 2018-2028)
In Vitro Fertilization (IVF)
In vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI)
In vitro fertilization (IVF) without intracytoplasmic sperm injection (ICSI)
Artificial insemination
Frozen Embryo Transfer (FET)
End-Use Outlook (Revenue, USD Billion; 2018-2028)
Fertility clinics
The full regional analysis covers:
North America (United States, Canada, Mexico
Europe (UK, Italy, Germany, France, Rest of EU)
Asia-Pacific (India, Japan, China, South Korea, Australia, rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa, Rest of MEA)
The report offers a comprehensive understanding of the impact of the COVID-19 pandemic on the overall market growth and expansion. COVID-19 has affected the global economy by interfering with production and demand, causing market disruptions and inducing financial instability.
Request Report Customization @
Key Points of the Assisted Reproductive Technology (ART) Market:
Extensive Assisted Reproductive Technology (ART) Market Analysis Coverage
Key information on the regional breakdown of the industry in key geographies
Sweeping insights into vital market trends; current and emerging trends, and factors influencing market growth
Comprehensive coverage of the impact of the COVID-19 pandemic on the overall growth of the Assisted Reproductive Technology (ART) Market
Comprehensive data on major manufacturers and suppliers of Assisted Reproductive Technology (ART) Market
Thank you for reading our report. Report customization is available. To find out more, please contact us and our team will ensure the report is customized to your needs.
Take a look at our related reports:
Injectable Drug Delivery Market
Interventional Cardiology Market
3D Printing Market
Assistive Reproductive Technology Market
Quantum Dots Market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting firm with an extensive knowledge base on cutting-edge and potentially market-disrupting technologies that are expected to become more prevalent over the next decade.

Eric Lee
Emerging research
+91 90210 91709
write to us here
Visit us on social media: